Growth Metrics

Elevance Health (ELV) Cash from Operations (2016 - 2025)

Elevance Health (ELV) has disclosed Cash from Operations for 17 consecutive years, with 84000000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 88.1% to 84000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 4290000000.0, a 26.14% decrease, with the full-year FY2025 number at 4290000000.0, down 26.14% from a year prior.
  • Cash from Operations was 84000000.0 for Q4 2025 at Elevance Health, down from 1135000000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6469000000.0 in Q1 2023 to a low of 2971000000.0 in Q4 2023.
  • A 5-year average of 1746100000.0 and a median of 1964000000.0 in 2023 define the central range for Cash from Operations.
  • Peak YoY movement for Cash from Operations: crashed 190.79% in 2022, then soared 359.51% in 2025.
  • Elevance Health's Cash from Operations stood at 1672000000.0 in 2021, then plummeted by 190.79% to 1518000000.0 in 2022, then plummeted by 95.72% to 2971000000.0 in 2023, then surged by 123.76% to 706000000.0 in 2024, then crashed by 88.1% to 84000000.0 in 2025.
  • Per Business Quant, the three most recent readings for ELV's Cash from Operations are 84000000.0 (Q4 2025), 1135000000.0 (Q3 2025), and 2054000000.0 (Q2 2025).